FORM
8-K
|
Florida
|
1-13165
|
59-2417093
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
·
|
non-GAAP
revenue growth, which has been obtained by adjusting the comparable GAAP
revenue growth number to exclude revenues related to orthopedic tissue
preservation services;
|
·
|
combined
cardiac and vascular preservation services revenues, which have been
obtained by adjusting the comparable tissue preservation segment revenue
numbers to exclude revenues related to orthopedic tissue preservation
services; and
|
·
|
projections
of product and tissue processing revenues for fiscal 2008 and 2009, which
have been obtained by adjusting the comparable projected GAAP revenues to
exclude other revenues.
|
·
|
the
ability to make more meaningful period-to-period comparisons of the
Company’s on-going operating
results;
|
·
|
the
ability to better identify trends in the Company’s underlying business and
perform related trend analyses; and
|
·
|
a
better understanding of how management plans and measures the Company’s
underlying business.
|
Exhibit Number
|
Description
|
|
99.1*
|
Press
release dated October 30,
2008
|
|
* This
exhibit is furnished, not
filed.
|
CRYOLIFE,
INC.
|
||
Date: October
30, 2008
|
By:
|
/s/ D.A. Lee
|
Name:
|
D.
Ashley Lee
|
|
Title:
|
Executive
Vice President, Chief
|
|
Operating
Officer and Chief
|
||
Financial
Officer
|